Zoommed Inc. (TSXV:ZMD), which has closed the sale of all of its ownership of intellectual property rights of PraxisLab' to Familiprix, is looking for acquisitions. Chief Executive Officer, Yves Marmet indicated that the proceeds of this transaction will allow ZoomMed to focus on its US operations, featuring its ZRx Prescriber technology, and will accelerate its market penetration through strategic partnerships, license agreements and acquisitions.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.65M | |
+8.90% | 33.88B | |
+21.99% | 8.35B | |
+30.81% | 4.24B | |
-29.43% | 2.67B | |
-15.87% | 1.45B | |
-25.17% | 1.33B | |
-33.46% | 1.16B | |
+12.19% | 1B | |
-36.34% | 892M |
- Stock Market
- Equities
- ZMD.H Stock
- News ZoomMed Inc.
- Zoommed Mulls Acquisitions